Leiden Drug Development Conference
Van derden19/09/24
After two successful previous editions, the 3rd edition of Leiden Drug Development Conference (LDDC) is set to take place on 19 September 2024. Organized by LUMC, Leiden University, Johnson & Johnson, and TNO, LDDC-3 promises to be a groundbreaking event. In an era of rapid technological advancement, artificial intelligence (AI) is transforming industries worldwide. Therefore, the entire LDDC-3 conference is dedicated to exploring AI’s impact on drug development, manufacturing, and healthcare. The program covers a wide spectrum, from advanced interaction modeling of 3D protein structures to extracting relevant insights from federated patient data, and will also address the ethical and practical implications of AI applications.
Whether you’re a researcher, clinician, industry professional or curious about the future of medicine, LDDC-3 welcomes you. Join for insightful talks, interactive workshops, and networking opportunities.
📅 September 19, 2024
Register now by visiting the conference website.
